Hester Biosciences Limited (HESTERBIO)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
1823.2
-16.4(-0.89%)

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Pricing Updates

TODAY'S HIGH

1855

TODAY'S LOW

1820

52 WEEK HIGH

2949.6

52 WEEK LOW

1817.7

Major Holders

% of Shares Held by
All Insider

63.34%

% of Shares Held by
Institutions

0.48%

% of Float Held by
Institutions

1.31%

Number of Institutions
Holding Shares

5

Company Overview

MARKET CAP

1552.13 Cr.

ETERPRISE VALUE

1916.79 Cr.

NO. OF SHARES

85.06 Lakhs

BOOK VALUE

295.582

DIV. YIELD

10%

DEBT

267.06 Cr.

GROSS PROFIT

180.95 Cr.

CASH

18.18 Cr.

REVENUE

251.42 Cr.

REVENUE/SHARE

291.275

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments01.06 Cr.-2.33 Cr.65.89 Lakhs
Change To Liabilities08.06 Cr.9.86 Cr.61.05 Lakhs
Total cashflows from Investing Activities0-38.37 Cr.-74.47 Cr.-21.72 Cr.
Net Borrowings0-22.89 Cr.28.16 Cr.18.96 Cr.
Total Cash from Financing Activities0-18.21 Cr.18.74 Cr.2.65 Cr.
Other Liabilities0-18.83 Cr.15.20 Cr.-8.38 Cr.
Total Assets0000
Net Income034.43 Cr.29.17 Cr.41.56 Cr.
Change in Cash0-2.26 Cr.-17.11 Cr.28.31 Cr.
Effect of Exchange Rate0-3.72 Cr.1.84 Cr.1.84 Cr.
Total Cash from Operating Activities058.05 Cr.36.77 Cr.46.70 Cr.
Depreciation013.26 Cr.13.17 Cr.11.69 Cr.
Other Cashflows from Investing Activities01.26 Cr.37.40 Lakhs15.23 Lakhs
Dividends Paid0-5.61 Cr.-5.95 Cr.-10.25 Cr.
Change to Inventory01.74 Cr.-13.18 Cr.-10.36 Cr.
Change to Account Receivables08.24 Cr.-25.63 Cr.5.88 Cr.
Other Cashflows from Financing Activities010.29 Cr.-3.47 Cr.-6.05 Cr.
Change to Net Income011.08 Cr.8.11 Cr.4.89 Cr.
Capital Expenditures0-40.74 Cr.-73.49 Cr.-22.65 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax050.10 Cr.41.32 Cr.56.85 Cr.
Minority Interest07.65 Cr.5.42 Cr.3.69 Cr.
Net Income059.12 Cr.46.85 Cr.62.57 Cr.
Selling General Administrative045.88 Cr.53.70 Cr.28.92 Cr.
Gross Profit0164.98 Cr.157.51 Cr.155.69 Cr.
Ebit059.12 Cr.46.85 Cr.62.57 Cr.
Operating Income059.12 Cr.46.85 Cr.62.57 Cr.
Other Operating Expenses045.98 Cr.43.82 Cr.52.42 Cr.
Interest Expense0-6.06 Cr.-6.38 Cr.-5.30 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense015.40 Cr.10.32 Cr.16.16 Cr.
Total Revenue0217.69 Cr.187.76 Cr.184.16 Cr.
Total Operating Expenses0158.57 Cr.140.90 Cr.121.58 Cr.
Cost of Revenue052.70 Cr.30.24 Cr.28.47 Cr.
Total Other Income Expense Net0-9.01 Cr.-5.53 Cr.-5.72 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.034.69 Cr.31 Cr.40.69 Cr.
Net Income Applicable to Common Shares034.43 Cr.29.17 Cr.41.56 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets042.10 Lakhs39.30 Lakhs47.98 Lakhs
Capital Surplus017.50 Cr.17.50 Cr.17.50 Cr.
Total Liabilities0175.09 Cr.180.11 Cr.118.29 Cr.
Stock Holder Equity0228.30 Cr.201.07 Cr.177.45 Cr.
Minority Interest07.65 Cr.5.42 Cr.3.69 Cr.
Other Liabilities08.54 Cr.18.34 Cr.7.47 Cr.
Total Assets0411.04 Cr.386.60 Cr.299.45 Cr.
Common Stock08.50 Cr.8.50 Cr.8.50 Cr.
Retained Earnings0193.47 Cr.164.44 Cr.143.19 Cr.
Other Liabilities025.69 Cr.14.97 Cr.11.28 Cr.
Good Will0000
Treasury Stock08.82 Cr.10.61 Cr.8.24 Cr.
Other Assets04.98 Cr.6.73 Cr.4.34 Cr.
Cash021.26 Cr.23.53 Cr.40.64 Cr.
Current Liabilities061.36 Cr.83.46 Cr.48.66 Cr.
Long Term Asset Charges0000
Short Long Term Debt018.28 Cr.11.50 Cr.8.92 Cr.
Other Stockholder Equity08.82 Cr.10.61 Cr.8.24 Cr.
Property Plant Equipment0241.33 Cr.216.29 Cr.151.39 Cr.
Total Cur. Assets0161.50 Cr.159.31 Cr.141.65 Cr.
Long Term Investments02.80 Cr.3.86 Cr.1.58 Cr.
Net Tangible Assets0227.88 Cr.200.67 Cr.176.97 Cr.
Short Term Investments0000
Net Receivables067.45 Cr.58.74 Cr.33.23 Cr.
Long Term Debt082.50 Cr.75.67 Cr.58.10 Cr.
Inventory062.22 Cr.63.96 Cr.50.78 Cr.
Accounts Payable028.08 Cr.20.02 Cr.8.75 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account